I agree that this site is using cookies. You can find further informations here.
X
Chaves-Conde, Manuel
26  results:
OpenAccess-fulltext X
Search for persons X
?
1

Afatinib vs Placebo as Adjuvant Therapy After Chemoradiothe..:

Burtness, Barbara ; Haddad, Robert ; Dinis, José...
http://hdl.handle.net/10668/14105.  , 2019
Link: http://hdl.handle.net/10..
 
?
2

Phosphorylation of gH2AX as a novel prognostic biomarker fo..:

Jose de Miguel-Luken, Maria ; Chaves-Conde, Manuel ; Quintana, Begona...
http://hdl.handle.net/10668/19430.  , 2016
Link: http://hdl.handle.net/10..
 
?
3

Phosphorylation of gH2AX as a novel prognostic biomarker fo..:

de Miguel-Luken, María José ; Chaves-Conde, Manuel ; Quintana, Begoña...
http://hdl.handle.net/10668/10071.  , 2016
Link: http://hdl.handle.net/10..
 
?
4

Phosphorylation of gH2AX as a novel prognostic biomarker fo..:

Miguel-Luken, María José de ; Chaves-Conde, Manuel ; Quintana, Begoña...
Publisher's version.  , 2016
Link: http://hdl.handle.net/10..
 
?
5

A genetic view of laryngeal cancer heterogeneity:

de Miguel-Luken, María José ; Chaves-Conde, Manuel ; Carnero, Amancio
http://hdl.handle.net/10668/9892.  , 2016
Link: http://hdl.handle.net/10..
 
?
6

A genetic view of laryngeal cancer heterogeneity:

de Miguel-Luken, María José ; Chaves-Conde, Manuel ; Carnero, Amancio
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894505/.  , 2016
Link: http://www.ncbi.nlm.nih...
 
?
7

MAP17 (PDZKIP1) as a novel prognostic biomarker for larynge..:

Miguel-Luken, María José de ; Chaves-Conde, Manuel ; Miguel-Luken, Verónica de...
Publisher's version.  , 2015
Link: http://hdl.handle.net/10..
 
?
8

A colorectal cancer susceptibility new variant at 4q26 in t..:

Real, Luis M ; Ruiz, Agustín ; Gayán, Javier...
Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0101178.  , 2014
Link: http://hdl.handle.net/24..
 
?
9

DataSheet_1_TTCC-2019-02: real-world evidence of first-line..:

Jordi Rubió-Casadevall ; Beatriz Cirauqui Cirauqui ; Javier Martinez Trufero...
doi:10.3389/fonc.2023.1226939.s001.  , 2023
Link: https://doi.org/10.3389/..
 
?
10

TTCC-2019-02: real-world evidence of first-line cetuximab p..:

Jordi Rubió-Casadevall ; Beatriz Cirauqui Cirauqui ; Javier Martinez Trufero...
https://www.frontiersin.org/articles/10.3389/fonc.2023.1226939/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
11

Lenvatininb as Treatment for Naïve Patients with Aggressive..:

Sonia Garcia-Rodriguez ; Guillermo Martinez Pinillos ; Manuel Chaves-Conde
http://dx.doi.org/10.1155/2020/8679149.  , 2020
Link: https://doi.org/10.1155/..
 
?
12

A colorectal cancer susceptibility new variant at 4q26 in t..:

Luis M Real ; Agustín Ruiz ; Javier Gayán...
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24978480/pdf/?tool=EBI.  , 2014
Link: https://doi.org/10.1371/..
 
?
13

TTCC-2019-02: real-world evidence of first-line cetuximab p..:

Rubió-Casadevall, Jordi ; Cirauqui Cirauqui, Beatriz ; Martinez Trufero, Javier...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432957/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
14

Prevention of oral mucositis secondary to antineoplastic tr..:

Pachón Ibáñez, Jerónimo ; Pereira Cunill, José Luis ; Osorio Gómez, Guiovana Fernanda...
http://hdl.handle.net/10668/12460.  , 2018
Link: http://hdl.handle.net/10..
 
?
15

Genetic analysis of caveolin-1 and eNOS genes in colorectal..:

Chaves Conde, Manuel ; Ramirez-Lorca, Reposo ; Esteban Lopez-Jamar, Jose Miguel...
http://www.spandidos-publications.com/or/16/2/353.  , 2006
Link: http://hdl.handle.net/10..
 
1-15